Eunice Nduati

The plasma concentration of the B cell activating factor is increased in children with acute malaria.Nduati E, Gwela A, Karanja H, Mugyenyi C, Langhorne J, Marsh K, Urban BC
J Infect Dis, (2011). 204:962-70

Distinct kinetics of memory B-cell and plasma-cell responses in peripheral blood following a blood-stage Plasmodium chabaudi infection in mice.Nduati EW, Ng DH, Ndungu FM, Gardner P, Urban BC, Langhorne J
PLoS One, (2010). 5:e15007

Effect of folate derivatives on the activity of antifolate drugs used against malaria and cancer.Nduati E, Diriye A, Ommeh S, Mwai L, Kiara S, Masseno V, Kokwaro G, Nzila A
Parasitol Res, (2008). 102:1227-34

Multiple synergistic interactions between atovaquone and antifolates against Plasmodium falciparum in vitro: a rational basis for combination therapy.Nduati EW, Kamau EM
Acta Trop, (2006). 97:357-63

2,4-diaminopteridine-based compounds as precursors for de novo synthesis of antifolates: a novel class of antimalarials.Nduati E, Hunt S, Kamau EM, Nzila A
Antimicrob Agents Chemother, (2005). 49:3652-7

Why has the dihydrofolate reductase 164 mutation not consistently been found in Africa yet?.Nzila A, Ochong E, Nduati E, Gilbert K, Winstanley P, Ward S, Marsh K
Trans R Soc Trop Med Hyg, (2005). 99:341-6

In vitro activities of 2,4-diaminoquinazoline and 2,4-diaminopteridine derivatives against Plasmodium falciparum.Ommeh S, Nduati E, Mberu E, Kokwaro G, Marsh K, Rosowsky A, Nzila A
Antimicrob Agents Chemother, (2004). 48:3711-4

Plasmodium falciparum: in vitro activity of sulfadoxine and dapsone in field isolates from Kenya: point mutations in dihydropteroate synthase may not be the only determinants in sulfa resistance.Mberu EK, Nzila AM, Nduati E, Ross A, Monks SM, Kokwaro GO, Watkins WM, Hopkins Sibley C
Exp Parasitol, (2002). 101:90-6

Genetic diversity of Plasmodium falciparum parasites from Kenya is not affected by antifolate drug selection.Nzila AM, Mberu EK, Nduati E, Ross A, Watkins WM, Sibley CH
Int J Parasitol, (2002). 32:1469-76

Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania.Mutabingwa T, Nzila A, Mberu E, Nduati E, Winstanley P, Hills E, Watkins W
Lancet, (2001). 358:1218-23

Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate Pyrimethamine/Sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum.Nzila AM, Nduati E, Mberu EK, Hopkins Sibley C, Monks SA, Winstanley PA, Watkins WM
J Infect Dis, (2000). 181:2023-8